Susan Mulryan, LSCSW | |
221 W Main St, Council Grove, KS 66846-1704 | |
(785) 564-0865 | |
Not Available |
Full Name | Susan Mulryan |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 31 Years |
Location | 221 W Main St, Council Grove, Kansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538106877 | NPI | - | NPPES |
069374 | Other | KS | BCBS NUMBER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 1756 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Susan Mulryan, LSCSW 203 7th St, Po Box 173, Dwight, KS 66849-9596 Ph: (785) 564-0865 | Susan Mulryan, LSCSW 221 W Main St, Council Grove, KS 66846-1704 Ph: (785) 564-0865 |
News Archive
Even long after it is formed, a memory in rats can be enhanced or erased by increasing or decreasing the activity of a brain enzyme, say researchers supported, in part, by the National Institutes of Health.
"In a speech to the Clinton Global Initiative on Tuesday, Republican presidential nominee Mitt Romney acknowledged the value of foreign aid and its purpose: providing humanitarian assistance, improving security and encouraging economic growth," but "we don't know whether he would really protect the current budget ... from further cuts if he is elected," a New York Times editorial states.
Case Western Reserve University School of Medicine researchers have identified a major indicator of two deadly diseases of the heart and blood vessels: heart failure and aortic aneurysm. The absence of the Kruppel-like Factor 15, when combined with stress, leads to both heart failure and aortic aneurysms.
Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin") in 17 countries in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. which has a business foundation in Latin America.
› Verified 2 days ago